Default: Clinical Pharmacology in Drug Development

ISSN: 2160-763X

Journal Home

Journal Guideline

Clinical Pharmacology in Drug Development Q2 Unclaimed

Wiley-Blackwell United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Clinical Pharmacology in Drug Development is a journal indexed in SJR in Pharmaceutical Science and Pharmacology (medical) with an H index of 30. It has a price of 2500 €. It has an SJR impact factor of 0,637 and it has a best quartile of Q2. It has an SJR impact factor of 0,637.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Price

2500 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

Clinical Pharmacology in Drug Development

0,637

SJR Impact factor

30

H Index

159

Total Docs (Last Year)

358

Total Docs (3 years)

3674

Total Refs

762

Total Cites (3 years)

342

Citable Docs (3 years)

2.15

Cites/Doc (2 years)

23.11

Ref/Doc

Comments

No comments ... Be the first to comment!



Best articles by citations

Aspartame - Is there new information?

View more

A Thorough QT Study to Evaluate the Effects of a Supratherapeutic Dose of Sertraline on Cardiac Repolarization in Healthy Subjects

View more

A thorough QT/QTc study of the effect of fasiglifam, a GPR40 agonist, on cardiac repolarization in healthy adults

View more

Pharmacokinetics, Safety, and Tolerability Evaluation of Single and Multiple Doses of GSK3342830 in Healthy Volunteers

View more

Pharmacokinetics, Safety, and Tolerability Following the Administration of a Single Dose of a Combination Tablet Containing Sumatriptan and Naproxen Sodium in Adolescent Patients With Migraine and in Healthy Adult Volunteers

View more

Pharmacokinetics, Safety, and Tolerability of Once-Daily Intranasal Fluticasone Furoate and Levocabastine Administered Alone or Simultaneously as fluticasone Furoate/Levocabastine Fixed-Dose Combination

View more

Bioavailability and Safety of the Factor Xa Inhibitor Edoxaban and the Effects of Quinidine in Healthy Subjects

View more

Pharmacokinetic Profile of Orally Administered Scyllo-Inositol (Elnd005) in Plasma, Cerebrospinal Fluid and Brain, and Corresponding Effect on Amyloid-Beta in Healthy Subjects

View more

Bioavailability of Clindamycin From a New Clindamycin Phosphate 1.2%-Benzoyl Peroxide 3% Combination Gel

View more

A Novel Study Using Accelerated Mass Spectrometry to Evaluate the Pharmacokinetics of Total 14C AL-8309 (Tandospirone) Following Topical Ocular Administration in Healthy Male Subjects

View more

Pharmacokinetic Studies of Cysteamine Bitartrate Delayed-Release

View more

Volume of distribution - Again

View more
SHOW MORE ARTICLES

Effects of Trastuzumab Emtansine (T-DM1) on QT Interval and Safety of Pertuzumab Plus T-DM1 in Patients With Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer

View more

Randomized, Double-Blind, Single-Dose, Placebo-Controlled Crossover Study to Evaluate the Effects of Esaxerenone on QTc Interval in Healthy Subjects

View more

Effects of icosapent ethyl (Eicosapentaenoic acid ethyl ester) on pharmacokinetic parameters of rosiglitazone in healthy subjects

View more

An evaluation of the systemic bioavailability of mometasone furoate (MF) after oral inhalation from a MF/formoterol fumarate metered-dose inhaler versus an MF dry-powder inhaler in healthy subjects

View more

Relative Bioavailability of an Emulsion Formulation for Omega-3-Acid Ethyl Esters Compared to the Commercially Available Formulation: A Randomized, Parallel-Group, Single-Dose Study Followed by Repeat Dosing in Healthy Volunteers

View more

A comparative pharmacokinetic and pharmacodynamic study of FSK0808 versus reference filgrastim after repeated subcutaneous administration in healthy Japanese men

View more

Relative Bioavailability of Liquid and Tablet Formulations of the Antiparasitic Moxidectin

View more

A pharmacokinetic, pharmacodynamic, and safety study of intravenous cyclophosphamide with an oral casopitant antiemetic regimen in cancer patients

View more

Pharmacokinetics and adhesion of a transdermal patch containing ethinyl estradiol and gestodene under conditions of heat, humidity, and exercise: A single-center, open-label, randomized, crossover study

View more

A Phase 1 Randomized, Placebo-Controlled Trial With a Topical Inhibitor of Stearoyl-Coenzyme A Desaturase 1 Under Occluded and Nonoccluded Conditions

View more

A Phase 1 Study to Evaluate the Bioavailability and Food Effect of 2 Solid-Dispersion Formulations of the TRPV1 Antagonist ABT-102, Relative to the Oral Solution Formulation, in Healthy Human Volunteers

View more

Pharmacokinetics and Bioequivalence Evaluation of 2 Cefadroxil Suspensions in Healthy Egyptian Male Volunteers

View more

FAQS